1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, September 2015 (p20)

Biological Therapy Analysis & Statistics, September 2015 (p20)

24/7 Customer Support

Talk to Veronica

+44 207 0971 241

571-600 of about 1 000 reports

Purchase Reports From Reputable Market Research Publishers

The 2016-2021 Outlook for Regenerative Medicine in the United States

The 2016-2021 Outlook for Regenerative Medicine in the United States

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for regenerative medicine across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings ...

  • Industries : Biological Therapy
  • Countries : United States
Ischemic Stroke - Pipeline Review, H2 2015

Ischemic Stroke - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Ischemic Stroke - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Ischemic Stroke - Pipeline Review, H2 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
CHA Bio & Diostech Co., Ltd. - Product Pipeline Review - 2015

CHA Bio & Diostech Co., Ltd. - Product Pipeline Review - 2015

  • € 1 200
  • Company report
  • September 2015
  • by Global Markets Direct

CHA Bio & Diostech Co., Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘CHA Bio & Diostech Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the CHA Bio ...

  • Industries : Therapy, Pathology, Research and Development, Biological Therapy
  • Countries : United States
Paralysis - Pipeline Review, H2 2015

Paralysis - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Paralysis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Paralysis - Pipeline Review, H2 2015’, provides an overview of the Paralysis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Mental Health
  • Countries : United States
Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2015

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2015’, provides an overview ...

  • Industries : Cancer, Pathology, Therapy, Biopharmaceutical
  • Countries : United States
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2015

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline ...

  • Industries : Therapy, Research and Development, Pharmaceutical
  • Countries : United States
Myocardial Infarction - Pipeline Review, H2 2015

Myocardial Infarction - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Myocardial Infarction - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Myocardial Infarction - Pipeline Review, H2 2015’, provides an overview of the Myocardial Infarction’s therapeutic ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Takara Bio Inc. - Product Pipeline Review - 2015

Takara Bio Inc. - Product Pipeline Review - 2015

  • € 1 200
  • Company report
  • September 2015
  • by Global Markets Direct

Takara Bio Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Takara Bio Inc. - Product Pipeline Review - 2015’, provides an overview of the Takara Bio Inc.’s pharmaceutical ...

  • Industries : Biological Therapy
  • Countries : United States, Japan, World
The 2016-2021 Outlook for Regenerative Medicine in India

The 2016-2021 Outlook for Regenerative Medicine in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for regenerative medicine across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : India
The 2016-2021 Outlook for Gene Therapy in India

The 2016-2021 Outlook for Gene Therapy in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for gene therapy across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings ...

  • Industries : Biological Therapy
  • Countries : India
The 2016-2021 Outlook for Therapeutic Vaccines in India

The 2016-2021 Outlook for Therapeutic Vaccines in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for therapeutic vaccines across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : India
The 2016-2021 Outlook for Stem Cell Products in India

The 2016-2021 Outlook for Stem Cell Products in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for stem cell products across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : India
The 2016-2021 Outlook for Cell/tissue Culture Reagents in India

The 2016-2021 Outlook for Cell/tissue Culture Reagents in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for cell/tissue culture reagents across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential ...

  • Industries : Biological Therapy
  • Countries : India
The 2016-2021 Outlook for Brachytherapy Technologies in India

The 2016-2021 Outlook for Brachytherapy Technologies in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for brachytherapy technologies across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential ...

  • Industries : Biological Therapy
  • Countries : India
The 2016-2021 Outlook for Cell/tissue Culture Sera in India

The 2016-2021 Outlook for Cell/tissue Culture Sera in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for cell/tissue culture Sera across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential ...

  • Industries : Biological Therapy
  • Countries : India
The 2016-2021 Outlook for Cell/tissue Culture Supplies in India

The 2016-2021 Outlook for Cell/tissue Culture Supplies in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for cell/tissue culture supplies across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential ...

  • Industries : Biological Therapy
  • Countries : India
The 2016-2021 Outlook for Cell and Tissue Culture Supplies in India

The 2016-2021 Outlook for Cell and Tissue Culture Supplies in India

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for cell and tissue culture supplies across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential ...

  • Industries : Biological Therapy
  • Countries : India
Advances in Gene Therapy (TechVision) 

Advances in Gene Therapy (TechVision) 

  • € 3 960
  • Industry report
  • September 2015
  • by Frost & Sullivan

Advances in Gene Therapy (TechVision) : Technology and Market Trends The objective of this research service is to provide an exhaustive analysis of the current trends in gene therapy. The research service ...

  • Industries : Biological Therapy
Refractory Anemia With Excess Blasts Global Clinical Trials Review, H2, 2015

Refractory Anemia With Excess Blasts Global Clinical Trials Review, H2, 2015

  • € 2 000
  • Industry report
  • September 2015
  • by Global Data

Refractory Anemia With Excess Blasts Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Refractory Anemia With Excess Blasts Global Clinical Trials Review, H2, 2015" ...

  • Industries : Pathology, Cancer
  • Countries : World
Severe Combined Immune Deficiency (SCID) Global Clinical Trials Review, H2, 2015

Severe Combined Immune Deficiency (SCID) Global Clinical Trials Review, H2, 2015

  • € 2 000
  • Industry report
  • September 2015
  • by Global Data

Severe Combined Immune Deficiency (SCID) Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Severe Combined Immune Deficiency (SCID) Global Clinical Trials Review, ...

  • Industries : Therapy, Pharmaceutical, Biological Therapy, Biopharmaceutical, Biotechnology, Pathology
  • Countries : World
Cardiomyopathy - Pipeline Review, H2 2015

Cardiomyopathy - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Cardiomyopathy - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Cardiomyopathy - Pipeline Review, H2 2015’, provides an overview of the Cardiomyopathy’s therapeutic pipeline. This report ...

  • Industries : Chronic Disease, Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Liver Cirrhosis - Pipeline Review, H2 2015

Liver Cirrhosis - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Liver Cirrhosis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Liver Cirrhosis - Pipeline Review, H2 2015’, provides an overview of the Liver Cirrhosis’s therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : United States
Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2015’, provides an overview of the Graft Versus ...

  • Industries : Blood Supply, Tissue Banking and Transplantation, Healthcare, Therapy, Pathology
  • Countries : United States
TiGenix NV - Product Pipeline Review - 2015

TiGenix NV - Product Pipeline Review - 2015

  • € 1 200
  • Company report
  • September 2015
  • by Global Markets Direct

TiGenix NV - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘TiGenix NV - Product Pipeline Review - 2015’, provides an overview of the TiGenix NV’s pharmaceutical research and ...

  • Industries : Research and Development
  • Countries : World, Spain, United States
Lysosomal Storage Disorder - Pipeline Review, H2 2015

Lysosomal Storage Disorder - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Lysosomal Storage Disorder - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Lysosomal Storage Disorder - Pipeline Review, H2 2015’, provides an overview of the Lysosomal Storage Disorder’s ...

  • Industries : Therapy, Research and Development, Pathology, Pharmaceutical
  • Countries : United States
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2015

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2015

  • € 1 600
  • Company report
  • September 2015
  • by Global Markets Direct

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2015’, provides an overview of ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States
The 2016-2021 Outlook for Therapeutic Vaccines in Japan

The 2016-2021 Outlook for Therapeutic Vaccines in Japan

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for therapeutic vaccines across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings ...

  • Industries : Biological Therapy
  • Countries : Japan
The 2016-2021 Outlook for Stem Cell Products in Japan

The 2016-2021 Outlook for Stem Cell Products in Japan

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for stem cell products across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) ...

  • Industries : Biological Therapy
  • Countries : Japan
The 2016-2021 Outlook for Stem Cell Products in Greater China

The 2016-2021 Outlook for Stem Cell Products in Greater China

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for stem cell products across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang ...

  • Industries : Biological Therapy
  • Countries : China
The 2016-2021 Outlook for Regenerative Medicine in Greater China

The 2016-2021 Outlook for Regenerative Medicine in Greater China

  • € 476
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for regenerative medicine across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang ...

  • Industries : Biological Therapy
  • Countries : China

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.